Literature DB >> 18347044

Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.

Bing Pang1, Dana Winn, Ryan Johnson, Wenzhou Hong, Shayla West-Barnette, Nancy Kock, W Edward Swords.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) causes pulmonary infections in patients with chronic obstructive pulmonary disease and other mucociliary clearance defects. Like many bacteria inhabiting mucosal surfaces, NTHi produces lipooligosaccharide (LOS) endotoxins that lack the O side chain. Persistent NTHi populations express a discrete subset of LOS glycoforms, including those containing phosphorylcholine (PCho). In this study, we compared two NTHi strains with isogenic mutants lacking PCho for clearance from mice following pulmonary infection. Consistent with data from other model systems, populations of the strains NTHi 2019 and NTHi 86-028NP recovered from mouse lung contained an increased proportion of PCho+ variants compared to that in the inocula. PCho- mutants were more rapidly cleared. Serial passage of NTHi increased both PCho content and bacterial resistance to clearance, and no such increases were observed for PCho- mutants. Increased PCho content was also observed in NTHi populations within non-endotoxin-responsive C3H/HeJ and Toll-like receptor 4 null (TLR4-/-) mice, albeit at later times postinfection. Changes in bacterial subpopulations and clearance were unaffected in TLR2-/- mice compared to the subpopulations in and clearance from mice of the parental strain. The clearance of PCho- mutants occurred at earlier time points in both strain backgrounds and in all types of mice. Comparison of bacterial populations in lung tissue cryosections by immunofluorescent staining showed sparse bacteria within the air spaces of C57BL/6 mice and large bacterial aggregates within the lungs of MyD88-/- mice. These results indicate that PCho promotes bacterial resistance to pulmonary clearance early in infection in a manner that is at least partially independent of the TLR4 pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347044      PMCID: PMC2346676          DOI: 10.1128/IAI.01716-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Toll-like receptors are temporally involved in host defense.

Authors:  David S Weiss; Bärbel Raupach; Kiyoshi Takeda; Shizuo Akira; Arturo Zychlinsky
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

2.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 3.  Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A.

Authors:  M A Apicella; J M Griffiss; H Schneider
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis.

Authors:  K Yi; S Sethi; T F Murphy
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

6.  Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.

Authors:  Wenzhou Hong; Kevin Mason; Joseph Jurcisek; Laura Novotny; Lauren O Bakaletz; W Edward Swords
Journal:  Infect Immun       Date:  2006-11-27       Impact factor: 3.441

7.  Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo.

Authors:  Wenzhou Hong; Bing Pang; Shayla West-Barnette; W Edward Swords
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

8.  Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.

Authors:  G B Toews; S Viroslav; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum.

Authors:  K Groeneveld; P P Eijk; L van Alphen; H M Jansen; H C Zanen
Journal:  Am Rev Respir Dis       Date:  1990-05

10.  Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein.

Authors:  J N Weiser; N Pan; K L McGowan; D Musher; A Martin; J Richards
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  30 in total

1.  A new human colonization model for nontypeable Haemophilus influenzae.

Authors:  Stephen J Barenkamp
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

2.  LuxS promotes biofilm maturation and persistence of nontypeable haemophilus influenzae in vivo via modulation of lipooligosaccharides on the bacterial surface.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E Dew; Richard A Juneau; Matthew S Byrd; Cheraton F Love; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  A novel zinc binding system, ZevAB, is critical for survival of nontypeable Haemophilus influenzae in a murine lung infection model.

Authors:  Charles V Rosadini; Jeffrey D Gawronski; Daniel Raimunda; José M Argüello; Brian J Akerley
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Internalization and trafficking of nontypeable Haemophilus influenzae in human respiratory epithelial cells and roles of IgA1 proteases for optimal invasion and persistence.

Authors:  Cara F Clementi; Anders P Håkansson; Timothy F Murphy
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

5.  Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.

Authors:  Stacey M Hartwig; Margaret Ketterer; Michael A Apicella; Steven M Varga
Journal:  Virology       Date:  2016-08-27       Impact factor: 3.616

6.  Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus.

Authors:  Kirk W McCrea; Jingping Xie; Carl F Marrs; Janet R Gilsdorf
Journal:  BMC Microbiol       Date:  2010-11-12       Impact factor: 3.605

7.  Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:  Patricia L Winokur; Kathryn Chaloner; Gary V Doern; Jennifer Ferreira; Michael A Apicella
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

8.  Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

9.  The Haemophilus influenzae Sap transporter mediates bacterium-epithelial cell homeostasis.

Authors:  Forrest K Raffel; Blake R Szelestey; Wandy L Beatty; Kevin M Mason
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.